Project Grant NUE1EH001460

Award Date 9/1/21
Completion Date 8/31/26
Dollars Obligated $1.2M
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.421
Assistance Type
Project Grant
Place of Performance
Bethesda, MD, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $898,497 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Radiopharmaceutical Imaging and Dosimetry, LLC to develop a cloud-based, customer-responsive dosimetry tool for alpha-particle emitting radiopharmaceutical therapies. The key objectives are to: 1) establish a library of microscale S-values and apportionment factors for dose-limiting tissues, 2) implement a macro-to-micro dosimetry methodology to enable...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $613,827 to Mayo Clinic Arizona to conduct research on improving radiation therapy delivery models and minimizing adverse events in spot scanning proton therapy. The key products and services to be delivered include: Developing a novel "Dose-LET Volume Histogram" tool to visualize and analyze the relationship between radiation dose, linear energy transfer (LET), and...
This Project Grant award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) to SRI International provides $401,125 in funding to quantify the association between genetic factors and radiation sensitivity in cancer patients. The research aims to identify germline genetic variants and gene expression patterns that contribute to individual differences in radiation response. The goal is to develop a predictive screening platform to optimize radiation dosing and mitigate...
The Department of Health and Human Services, Health Resources and Services Administration (HRSA) awarded a $647,019 Project Grant under the Grants for Education, Prevention, and Early Detection of Radiogenic Cancers and Diseases program (CFDA 93.257) to the Board of Regents of the Nevada System of Higher Education, doing business as the University of Nevada, Las Vegas (UNLV). The grant aims to provide comprehensive medical screenings, public health education, and support services to...
The National Cancer Institute (NCI) awarded a 5-year, $1,504,098 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to the Sloan-Kettering Institute for Cancer Research in New York. The grant, which commenced on May 6, 2025, seeks to identify genetic determinants of radiation-associated contralateral breast cancer (CBC) and develop a comprehensive model to estimate CBC risk. The research leverages the extensive WECARE study cohort of 1,233 CBC cases and 1,746 matched unilateral...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to Radiopharmaceutical Imaging And Dosimetry, LLC provides $1,003,173 to develop a prototype web/cloud-based quantitative SPECT reconstruction software system for clinical trials and dosimetry of radiopharmaceutical therapy (RPT) using alpha-emitting radionuclides. The goal is to create advanced quantitative imaging capabilities to support the precision medicine approach required for...
This federal Project Grant award from the U.S. Department of Health and Human Services (CFDA 93.257 - Grants for Education, Prevention, and Early Detection of Radiogenic Cancers and Diseases) provides $431,346 to North Country Healthcare, Inc. to operate the Radiation Exposure Screening and Education Program (RESEP) in northern Arizona. Through this 3-year grant awarded on September 1, 2024, North Country Healthcare will provide comprehensive medical screenings, diagnostic testing, treatment...
This Project Grant award from the U.S. Department of Health and Human Services Health Resources and Services Administration (HRSA) under the Grants for Education, Prevention, and Early Detection of Radiogenic Cancers and Diseases program (CFDA 93.257) provides $646,818.00 in funding to IHC Health Services Inc. (dba Intermountain Healthcare) to continue their Radiation Exposure Screening and Education Program (RESEP) clinic in southwestern Utah. The RESEP clinic provides cancer screenings,...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $667,485 to the University of California, San Diego to conduct a longitudinal study on radiation-induced neurocognitive decline in glioma patients. The key objectives are to: Characterize neurocognitive changes and identify cognitive phenotypes in glioma patients before and after radiation therapy (RT). Analyze mechanisms underlying RT-induced cognitive decline...
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded a $358,000 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to Brigham & Women's Hospital Inc. The project, titled "Nonresponse of Patient-Reported Outcomes in Routine Cancer Care," aims to characterize and address the issue of nonresponse in patient-reported outcome (PRO) data collection in routine cancer care. The project will (1) characterize nonresponse patterns...

RADIATION PROTECTION GUIDANCE FROM NCRP RELATED TO PUBLIC HEALTH - THE NATIONAL COUNCIL ON RADIATION PROTECTION AND MEASUREMENTS (NCRP) IS A NONPROFIT, CONGRESSIONALLY-CHARTERED ORGANIZATION WITH THE MISSION TO PROVIDE GUIDANCE, BASED ON THE BEST SCIENTIFIC EVIDENCE, TO THE GOVERNMENT, INDUSTRY, AND THE PUBLIC ON MATTERS RELATED TO RADIATION HEALTH PROTECTION AND MEASUREMENTS. NCRP WILL DEVELOP CONSENSUS GUIDANCE ON RADIATION HEALTH PROTECTION INVOLVING IONIZING AND NON-IONIZING RADIATION. BASED ON THE MOST UP-TO-DATE RADIATION SCIENCE KNOWLEDGE AVAILABLE, REPORTS AND OTHER DOCUMENTS WILL BE PREPARED TO HELP FEDERAL, STATE, AND LOCAL AGENCIES IN MAKING PUBLIC HEALTH DECISIONS AND IMPROVING PRACTICES. THE WORK FROM THE TARGETED PROJECT AREAS WILL CONTRIBUTE TO IMPROVED UNDERSTANDING OF RADIATION TO BETTER PROTECT THE PUBLIC, WORKERS, AND EMERGENCY RESPONDERS FROM EXPOSURES TO IONIZING AND NON-IONIZING RADIATION FROM NATURAL, MEDICAL, AND OCCUPATIONAL SOURCES, AS WELL AS RADIOLOGICAL DISASTERS. THE NET RESULT WILL BE IMPROVING COMPREHENSIVE RADIATION PROTECTION GUIDANCE FOR THE UNITED STATES. SIX MAJOR PROJECT AREAS ARE PROPOSED: (1) IN THE AREA OF MONITORING AND CONTROLLING EXPOSURES TO WORKERS AND THE PUBLIC DURING RADIOLOGICAL EMERGENCIES, A COMMENTARY WILL BE PREPARED TO RESOLVE INCONSISTENCIES IN RECOMMENDATIONS REGARDING SCREENING MEMBERS OF THE PUBLIC FOR EXTERNAL CONTAMINATION AFTER A NUCLEAR/RADIOLOGICAL INCIDENT, A DOCUMENT WILL BE PREPARED TO ASSESS NATIONAL EFFORTS IN EMERGENCY PREPAREDNESS AND RECOGNIZE GAPS IN NEED OF ATTENTION, AND A FOCUSED STATEMENT WILL BE DEVELOPED TO PROVIDE GUIDANCE TO INFORM ON A DOSIMETRY AND BIODOSIMETRY NETWORK TO IMPROVE TRIAGE AND MEDICAL MANAGEMENT IN THE EVENT OF A MASS-CASUALTY RADIATION INCIDENT.(2) A COMMENTARY WILL BE PREPARED WITH RECOMMENDATIONS FOR PRACTICAL IMPLEMENTATION OF METHODOLOGIES DESCRIBED PREVIOUSLY IN AN NCRP REPORT TO IMPROVE USE OF RADIATION PROTECTION EQUIPMENT AND PRACTICES FOR RADIATION EMERGENCY WORKERS, DEFINED AS THOSE WHO ASSIST IN CRITICAL ROLES IN A RADIOLOGICAL/NUCLEAR EMERGENCY BUT ARE NOT TRAINED OR ROUTINELY MONITORED FOR RADIATION EXPOSURES. (3) A COMPREHENSIVE REPORT WILL BE WRITTEN TO PROVIDE NATIONAL ENVIRONMENTAL AND RADIATION SAFETY GUIDELINES FOR THE MANAGEMENT AND DISPOSAL OF TECHNOLOGICALLY ENHANCED NATURALLY OCCURRING RADIOACTIVE MATERIALS (TENORM), IN PARTICULAR, ADDRESSING METHODS TO PROTECT HUMAN HEALTH AND THE ENVIRONMENT FROM UNNECESSARY RADIATION EXPOSURES.(4) A SERIES OF DOCUMENTS WILL BE PREPARED EVALUATING THE STATE-OF-THE-KNOWLEDGE ABOUT HEALTH EFFECTS OF MILLIMETER-WAVE 5TH GENERATION (5G) NETWORKS, RISK COMMUNICATIONS WITH THE PUBLIC ABOUT THESE POSSIBLE EFFECTS, INCLUDING PREPARING SCIENTIFICALLY-BASED INFORMATION RELATED TO WIDELY HELD MISCONCEPTIONS AND MISINFORMATION ABOUT THESE NETWORKS, AND RECOMMENDATIONS FOR FUTURE RESEARCH TO HELP ALLAY FEARS OF THE PUBLIC. (5) SEVERAL AVENUES WILL BE EMPLOYED TO IMPROVE COMMUNICATIONS TO THE PUBLIC OF RISKS FROM BOTH IONIZING AND NON-IONIZING RADIATION. THESE WILL INCLUDE IMPROVING PUBLIC ACCESS TO PUBLISHED NCRP INFORMATION AND RECOMMENDATIONS, DEVELOPING EDUCATIONAL MATERIALS FOR EDUCATORS, STUDENTS, AND MEMBERS OF THE PUBLIC TO BE AVAILABLE ON THE NCRP WEBSITE, AND PROVIDING EXTENSIVE COLLATION OF RESOURCES ON RADIATION RISK COMMUNICATIONS.(6) EXTENDING NCRP?S LONG HISTORY OF PROVIDING RECOMMENDATIONS ON RADIATION PROTECTION IN MEDICINE, NEW DOCUMENTS WILL ADDRESS RISKS FROM RADIATION EXPOSURE OF IMPLANTED AND APPLIED DEVICES (E.G., PACEMAKERS AND INSULIN PUMPS) AND USE OF PROTECTIVE SHIELDING IN IMAGING PROCEDURES. FURTHER, PROTOCOLS WILL BE DEVELOPED FOR UPDATING PRIOR COLLECTION OF CRITICAL INFORMATION ON MEDICAL RADIATION EXPOSURES OF PATIENTS.

Posted 8/3/21, 12:00 AM